rs1131692059
|
|
ESTROGEN RESISTANCE
|
A |
0.800 |
GeneticVariation
|
CLINVAR |
|
|
|
rs1131692059
|
|
ESTROGEN RESISTANCE
|
A |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs397509428
|
|
ESTROGEN RESISTANCE
|
T |
0.800 |
CausalMutation
|
CLINVAR |
|
|
|
rs796065354
|
|
Malignant neoplasm of breast
|
G |
0.760 |
SusceptibilityMutation
|
CLINVAR |
A population-based case-control study was conducted in 150 newly diagnosed invasive breast cancer and 147 healthy control individuals controls to screen for presence of the ER-α A908G mutation by using single-strand conformation polymorphism (SSCP) analysis and 33Pcycle DNA sequencing.
|
23236557 |
2013 |
rs796065354
|
|
Malignant neoplasm of breast
|
G |
0.760 |
SusceptibilityMutation
|
CLINVAR |
There was also the suggestion that longer duration of oral contraceptive (OC) use (OR = 3.73, 95% CI = 1.16 to 12.03; Ptrend = 0.02 for use of more than 10 years) and recent use of OCs (OR = 3.63, 95% CI = 0.80 to 16.45; Ptrend = 0.10 for use within 10 years) were associated with ESR1 A908G mutation-positive breast cancer; however, ORs for comparison of the two case subgroups were not statistically significant.
|
17553133 |
2007 |
rs796065354
|
|
Malignant neoplasm of breast
|
G |
0.760 |
SusceptibilityMutation
|
CLINVAR |
Here, we have optimized the detection of a somatic mutation, an A908G transition of ERalpha, and examined its association with clinical and biological features of invasive breast cancer.
|
17545528 |
2007 |
rs796065354
|
|
Malignant neoplasm of breast
|
G |
0.760 |
SusceptibilityMutation
|
CLINVAR |
This population-based study, the largest so far to screen for the ER-alpha A908G mutation in breast cancer, confirms the presence of the mutant in invasive breast tumors.
|
16280033 |
2005 |
rs796065354
|
|
Malignant neoplasm of breast
|
G |
0.760 |
SusceptibilityMutation
|
CLINVAR |
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions.
|
10945602 |
2000 |
rs104893956
|
|
ESTROGEN RESISTANCE
|
T |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1057519714
|
|
Mammary Neoplasms
|
C |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519715
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519716
|
|
Mammary Neoplasms
|
A |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519717
|
|
Mammary Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
|
24185510 |
2013 |
rs1057519717
|
|
Mammary Neoplasms
|
G |
0.700 |
CausalMutation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs1057519827
|
|
Mammary Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor-positive breast cancer.
|
24398047 |
2014 |
rs1057519827
|
|
Mammary Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Activating ESR1 mutations in hormone-resistant metastatic breast cancer.
|
24185510 |
2013 |
rs1057519827
|
|
Mammary Neoplasms
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
ESR1 ligand-binding domain mutations in hormone-resistant breast cancer.
|
24185512 |
2013 |
rs121913043
|
|
ESTROGEN RECEPTOR MUTANT, TEMPERATURE-SENSITIVE
|
GC |
0.700 |
CausalMutation
|
CLINVAR |
|
|
|
rs1562787582
|
|
ESTROGEN RESISTANCE
|
A |
0.700 |
SusceptibilityMutation
|
CLINVAR |
|
|
|